Efficacy of Probiotic Strains <i>Lactobacillus sakei</i> Probio65 and <i>Lactobacillus plantarum</i> Probio-093 in Management of Obesity: An In Vitro and In Vivo Analysis

The prevalence of obesity, characterized by an excessive accumulation of adipose tissue and adipocyte hypertrophy, presents a major public health challenge. This study investigates the therapeutic potential of two probiotic strains, <i>Lactobacillus sakei</i> Probio65 and <i>Lactob...

Full description

Saved in:
Bibliographic Details
Main Authors: Aneela Gulnaz (Author), Lee-Ching Lew (Author), Yong-Ha Park (Author), Jamal S. M. Sabir (Author), Raed Albiheyri (Author), Irfan A. Rather (Author), Yan-Yan Hor (Author)
Format: Book
Published: MDPI AG, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prevalence of obesity, characterized by an excessive accumulation of adipose tissue and adipocyte hypertrophy, presents a major public health challenge. This study investigates the therapeutic potential of two probiotic strains, <i>Lactobacillus sakei</i> Probio65 and <i>Lactobacillus plantarum</i> Probio-093, in the context of obesity. Utilizing 3T3-L1 cell-derived human adipocytes, we assessed Probio65's and Probio-093's capacity to mitigate triglyceride accumulation and influence adipocytokine production in vitro. Subsequently, an in vivo trial with male C57BL/6J mice examined the effects of both probiotic strains on adipose tissue characteristics, body weight, fat mass, and obesity-related gene expression. This study employed both live and ethanol-extracted bacterial cells. The results demonstrated significant reductions in the triglyceride deposition, body weight, and adipose tissue mass in the treated groups (<i>p</i> < 0.05). Furthermore, both strains modulated adipokine profiles by downregulating proinflammatory markers such as PAI-1, leptin, TNF-α, STAMP2, F4/80, resistin, and MCP-1, and upregulating the insulin-sensitive transporter GLUT4 and the anti-inflammatory adiponectin (<i>p</i> < 0.05). Our findings suggest that <i>Lactobacillus sakei</i> Probio65 and <i>Lactobacillus plantarum</i> Probio-093 are promising agents for microbiome-targeted anti-obesity therapies, offering the effective mitigation of obesity and improvement in adipocyte function in a murine model.
Item Description:10.3390/ph17060676
1424-8247